Developing new and safer influenza vaccines.
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component B: Vaccine Manufacturing and Toxicology Core
['FUNDING_OTHER'] · DUKE UNIVERSITY · NIH-11057541
This study is working on new flu vaccines that are safer and more effective, so people can get better protection against different types of the flu virus.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUKE UNIVERSITY (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-11057541 on ClinicalTrials.gov |
What this research studies
This research focuses on creating innovative influenza vaccine platforms that are safer and more effective. It involves advanced manufacturing techniques and thorough evaluations of the vaccines' safety and toxicity. Patients can benefit from the development of vaccines that may provide broader protection against various strains of the flu virus. The research aims to optimize these vaccines to ensure they are both effective and safe for public use.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are at high risk for influenza, such as the elderly, young children, and those with compromised immune systems.
Not a fit: Patients who are not at risk for influenza or those who have already received effective vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a universal influenza vaccine that provides long-lasting protection against multiple strains of the virus.
How similar studies have performed: Other research has shown promise in developing innovative vaccine platforms, but this specific approach is considered cutting-edge and may offer novel solutions.
Where this research is happening
DURHAM, UNITED STATES
- DUKE UNIVERSITY — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DENNY, THOMAS — DUKE UNIVERSITY
- Study coordinator: DENNY, THOMAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.